Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Century Therapeutics, Inc. (IPSC)

NASDAQ

$2.12

$+0.03

(+1.20%)

Regular Market

Century Therapeutics, Inc. (IPSC) Live Price Chart

Last updated: ⁦2026-09-04 16:06:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Century Therapeutics, Inc. (IPSC) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $2.12, with a market capitalisation of $382.07M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.44 to $3.04. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$382.07M
Open	$2.06
Day's High	$32.90
Day's Low	$0.34
Previous Close	$2.09
Volume	34.72K
Average Volume	--
P/E Ratio	--
52-Week High	$3.04
52-Week Low	$0.44
Dividend Yield	--
Earnings Date	--

Century Therapeutics, Inc. (IPSC) Stock Price Today

Century Therapeutics, Inc. (IPSC) is currently trading at $2.12 as of 2026-09-04 16:05:00, up 1.20% ($0.03) from the previous close of $2.09

During today's regular trading session, IPSC has traded between $0.34 and $32.90, with a trading volume of 34.72K shares. The current price is near the lower end of today's range.

Century Therapeutics, Inc. (IPSC) 7-Day Stock Price Change

Over the past seven days, Century Therapeutics, Inc. (IPSC) moved from $2.00 to $2.12, representing a gain of 5.75% ($0.12).

The stock traded between $2.06 and $2.12 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 385.32 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

IPSC 52-Week Price Position

Position in Range: 64.5%

52W Low$0.44

52W High$3.04

IPSC is currently trading at $2.12, placing it 64.5% of the way from its 52-week low of $0.44 to its 52-week high of $3.04. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Century Therapeutics, Inc. (IPSC)?

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Century Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	78
Exchange	NASDAQ
Company Website	https://www.centurytx.com

How to Buy Century Therapeutics, Inc. (IPSC) Stock on MEXC

Eligible investors can buy real shares of Century Therapeutics, Inc. (IPSC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for IPSC and Place Your Order

Open the RealStocks trading page and search for IPSC. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Century Therapeutics, Inc. (IPSC) stock price today?

Century Therapeutics, Inc. (IPSC) is currently trading at $ 2.12, up 1.20% ($0.03) from the previous close of $ 2.09. Intraday prices update in real time during regular trading hours.

2.Is IPSC stock going up or down today?

As of 2026-09-04 16:05:00, IPSC is trading at $ 2.12, up 1.20% ($0.03) from its previous close of $ 2.09. The stock has traded between $ 0.34 and $ 32.90 during today’s regular session. Past price movements do not guarantee future results.

3.What is IPSC pre-market price?

As of 2026-09-04 16:05:00, IPSC is trading at $ 2.08 in pre-market trading, down 0.29% ($0.01) from the previous close of $ 2.09. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is IPSC after-hours price?

As of 2026-09-04 16:05:00, IPSC is trading at -- in after-hours trading, -- from the regular-session close of $ 2.09. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is IPSC stock trading now?

IPSC trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does IPSC sit relative to its 52-week high and low?

Over the past 52 weeks, IPSC has traded between a low of $ 0.44 and a high of $ 3.04. At $ 2.12, the stock is positioned 64.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Century Therapeutics, Inc. in?

Century Therapeutics, Inc. (IPSC) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Century Therapeutics, Inc.'s market capitalisation and where is it listed?

Century Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 382.07M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is IPSC valued in terms of P/E ratio and EPS?

IPSC trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.61. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Century Therapeutics, Inc. pay a dividend?

Century Therapeutics, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.